Edition:
United States

Alchemia Ltd (ACL.AX)

ACL.AX on Australia Stock Exchange

0.01AUD
15 Feb 2019
Change (% chg)

$0.00 (+10.00%)
Prev Close
$0.01
Open
$0.01
Day's High
$0.01
Day's Low
$0.01
Volume
170,000
Avg. Vol
2,846,831
52-wk High
$0.02
52-wk Low
$0.01

Chart for

About

Alchemia Limited is a biotechnology company. The Company is engaged in the sale of its around the world intellectual property rights to Fondaparinum sodium, a generic anti-coagulant drug to Dr Reddy's Laboratories; closure of clinical trial activities, and review of new opportunities. The Company's segments include Fondaparinux... (more)
No analyst recommendations are available for .

Overall

Beta: -1.06
Market Cap(Mil.): $3.57
Shares Outstanding(Mil.): 324.72
Dividend: --
Yield (%): --

Financials

  ACL.AX Industry Sector
P/E (TTM): -- 88.11 35.99
EPS (TTM): -0.00 -- --
ROI: -18.54 10.12 12.72
ROE: -18.54 10.40 13.73

Earnings vs. Estimates